

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.93471061 |
| 2 | histone H3-K4 trimethylation (GO:0080182) | 4.35968190 |
| 3 | negative T cell selection (GO:0043383) | 4.35710083 |
| 4 | negative thymic T cell selection (GO:0045060) | 4.34075338 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31125837 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.29920102 |
| 7 | positive regulation of granulocyte differentiation (GO:0030854) | 4.24579998 |
| 8 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.89833479 |
| 9 | positive T cell selection (GO:0043368) | 3.70102072 |
| 10 | positive thymic T cell selection (GO:0045059) | 3.58194939 |
| 11 | Peyers patch development (GO:0048541) | 3.55728862 |
| 12 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.55728862 |
| 13 | thymic T cell selection (GO:0045061) | 3.55244749 |
| 14 | histone H3-K9 methylation (GO:0051567) | 3.53875705 |
| 15 | histone H3-K9 modification (GO:0061647) | 3.52636105 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.45626135 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45626135 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45078625 |
| 19 | T cell selection (GO:0045058) | 3.44494991 |
| 20 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.39470366 |
| 21 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.39470366 |
| 22 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.39470366 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.37013085 |
| 24 | histone H3-K36 demethylation (GO:0070544) | 3.29758718 |
| 25 | activated T cell proliferation (GO:0050798) | 3.26550531 |
| 26 | behavioral response to nicotine (GO:0035095) | 3.20150080 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19296068 |
| 28 | peptidyl-lysine trimethylation (GO:0018023) | 3.18620645 |
| 29 | cellular response to ethanol (GO:0071361) | 3.18093300 |
| 30 | histone H3-K4 methylation (GO:0051568) | 3.15906667 |
| 31 | regulation of granulocyte differentiation (GO:0030852) | 3.12965953 |
| 32 | peptidyl-lysine methylation (GO:0018022) | 3.10950266 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10322280 |
| 34 | L-fucose catabolic process (GO:0042355) | 3.09957769 |
| 35 | fucose catabolic process (GO:0019317) | 3.09957769 |
| 36 | L-fucose metabolic process (GO:0042354) | 3.09957769 |
| 37 | neural tube formation (GO:0001841) | 3.08197356 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.06868796 |
| 39 | protein K48-linked deubiquitination (GO:0071108) | 3.06652102 |
| 40 | regulation of histone H3-K27 methylation (GO:0061085) | 3.04625657 |
| 41 | response to interleukin-15 (GO:0070672) | 3.02548084 |
| 42 | cellular response to exogenous dsRNA (GO:0071360) | 2.99000524 |
| 43 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.96948010 |
| 44 | mannose metabolic process (GO:0006013) | 2.95661023 |
| 45 | histone lysine methylation (GO:0034968) | 2.94762132 |
| 46 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.93748260 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86397618 |
| 48 | regulation of memory T cell differentiation (GO:0043380) | 2.86364921 |
| 49 | interkinetic nuclear migration (GO:0022027) | 2.86294369 |
| 50 | rRNA catabolic process (GO:0016075) | 2.85671123 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81001609 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78658179 |
| 53 | tryptophan metabolic process (GO:0006568) | 2.74619786 |
| 54 | protein K11-linked deubiquitination (GO:0035871) | 2.74167742 |
| 55 | positive regulation of developmental pigmentation (GO:0048087) | 2.72046754 |
| 56 | T-helper cell differentiation (GO:0042093) | 2.71587008 |
| 57 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.71587008 |
| 58 | NAD biosynthetic process (GO:0009435) | 2.70111678 |
| 59 | T cell migration (GO:0072678) | 2.68199620 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67981807 |
| 61 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.67172072 |
| 62 | oxidative demethylation (GO:0070989) | 2.66564367 |
| 63 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.66128978 |
| 64 | positive regulation of defense response to virus by host (GO:0002230) | 2.64998106 |
| 65 | indole-containing compound catabolic process (GO:0042436) | 2.60870720 |
| 66 | indolalkylamine catabolic process (GO:0046218) | 2.60870720 |
| 67 | tryptophan catabolic process (GO:0006569) | 2.60870720 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 2.60643077 |
| 69 | S-adenosylmethionine metabolic process (GO:0046500) | 2.60129323 |
| 70 | drug catabolic process (GO:0042737) | 2.59905307 |
| 71 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59677618 |
| 72 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.58759798 |
| 73 | alpha-beta T cell differentiation (GO:0046632) | 2.56833281 |
| 74 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.56465413 |
| 75 | negative regulation of B cell mediated immunity (GO:0002713) | 2.56465413 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56340067 |
| 77 | tolerance induction (GO:0002507) | 2.51056634 |
| 78 | snRNA processing (GO:0016180) | 2.49612632 |
| 79 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.48769534 |
| 80 | histone lysine demethylation (GO:0070076) | 2.47046748 |
| 81 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.46894535 |
| 82 | exogenous drug catabolic process (GO:0042738) | 2.46366119 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 2.45959089 |
| 84 | snRNA transcription (GO:0009301) | 2.44647186 |
| 85 | negative regulation of adaptive immune response (GO:0002820) | 2.44605578 |
| 86 | histone methylation (GO:0016571) | 2.44553956 |
| 87 | positive regulation of mRNA catabolic process (GO:0061014) | 2.43251693 |
| 88 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.41240445 |
| 89 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.40787316 |
| 90 | negative regulation of protein oligomerization (GO:0032460) | 2.40620867 |
| 91 | histone H4-K16 acetylation (GO:0043984) | 2.39790323 |
| 92 | positive regulation of histone deacetylation (GO:0031065) | 2.39684590 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 2.37861241 |
| 94 | histone demethylation (GO:0016577) | 2.37777506 |
| 95 | embryonic hemopoiesis (GO:0035162) | 2.37712755 |
| 96 | alpha-beta T cell activation (GO:0046631) | 2.37558114 |
| 97 | hepatocyte apoptotic process (GO:0097284) | 2.37516798 |
| 98 | fatty acid transmembrane transport (GO:1902001) | 2.37191996 |
| 99 | DNA alkylation (GO:0006305) | 2.36284803 |
| 100 | DNA methylation (GO:0006306) | 2.36284803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.36842429 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.98544974 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75094388 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.67424178 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60133453 |
| 6 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.41708059 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.41583306 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30607151 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 2.27922835 |
| 10 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.25103634 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23467087 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.17478345 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15528223 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.14975912 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12217750 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.03125695 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99907113 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.98332696 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97754675 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97589639 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.96907378 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.92282470 |
| 23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91516202 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82083079 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.79138816 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.77028278 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.76915407 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75517463 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71963533 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62031527 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61041472 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59307302 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55388031 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.53335671 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52081770 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.49972535 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.47825725 |
| 38 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.44812957 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44244419 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40846269 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40807004 |
| 42 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39176951 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38650804 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35178413 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35117265 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34476673 |
| 47 | ERA_21632823_ChIP-Seq_H3396_Human | 1.33979706 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32880388 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32581384 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30041841 |
| 51 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28849255 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28815634 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27869770 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.26468262 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26384010 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26328065 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26149005 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24886239 |
| 59 | P300_27268052_Chip-Seq_Bcells_Human | 1.24196928 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21733613 |
| 61 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.20412781 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20202607 |
| 63 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.18397049 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18142934 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15835704 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15145331 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13538810 |
| 68 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.12330982 |
| 69 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12113199 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11657774 |
| 71 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11197482 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11134005 |
| 73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09600245 |
| 74 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.09533351 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09023401 |
| 76 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08784742 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08102682 |
| 78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05485946 |
| 79 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05282148 |
| 80 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03294848 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00986795 |
| 82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00915393 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00516636 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00440837 |
| 85 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00326290 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99937159 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98233991 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96830932 |
| 89 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.96823877 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96776180 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96372818 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95879027 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95196383 |
| 94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94721259 |
| 95 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94553704 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93917278 |
| 97 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.92988945 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89585543 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89068760 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88685984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.51687333 |
| 2 | MP0000569_abnormal_digit_pigmentation | 2.86196485 |
| 3 | MP0002009_preneoplasia | 2.76768461 |
| 4 | MP0001800_abnormal_humoral_immune | 2.55993025 |
| 5 | MP0004381_abnormal_hair_follicle | 2.41131193 |
| 6 | MP0001986_abnormal_taste_sensitivity | 2.33093816 |
| 7 | MP0003646_muscle_fatigue | 2.26772737 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.24151698 |
| 9 | MP0001873_stomach_inflammation | 2.16477027 |
| 10 | MP0000685_abnormal_immune_system | 2.13438245 |
| 11 | MP0005360_urolithiasis | 2.09036188 |
| 12 | MP0005671_abnormal_response_to | 1.93008060 |
| 13 | MP0008961_abnormal_basal_metabolism | 1.92577079 |
| 14 | MP0002396_abnormal_hematopoietic_system | 1.89058304 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 1.85269825 |
| 16 | MP0002723_abnormal_immune_serum | 1.84290603 |
| 17 | MP0003436_decreased_susceptibility_to | 1.81627910 |
| 18 | MP0001790_abnormal_immune_system | 1.81452485 |
| 19 | MP0005387_immune_system_phenotype | 1.81452485 |
| 20 | MP0003252_abnormal_bile_duct | 1.79233057 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.77101404 |
| 22 | MP0001819_abnormal_immune_cell | 1.73848536 |
| 23 | MP0004043_abnormal_pH_regulation | 1.72767914 |
| 24 | MP0002928_abnormal_bile_duct | 1.72265037 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.72023864 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.70031402 |
| 27 | MP0004130_abnormal_muscle_cell | 1.69783863 |
| 28 | MP0002398_abnormal_bone_marrow | 1.68346138 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.64712051 |
| 30 | MP0000703_abnormal_thymus_morphology | 1.59885500 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.59002833 |
| 32 | MP0000716_abnormal_immune_system | 1.58164195 |
| 33 | MP0008057_abnormal_DNA_replication | 1.57239452 |
| 34 | MP0003724_increased_susceptibility_to | 1.56610471 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52947974 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.49390425 |
| 37 | MP0008995_early_reproductive_senescence | 1.47247510 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.45318321 |
| 39 | MP0005025_abnormal_response_to | 1.45285974 |
| 40 | MP0005083_abnormal_biliary_tract | 1.44515619 |
| 41 | MP0002722_abnormal_immune_system | 1.43417404 |
| 42 | MP0008872_abnormal_physiological_respon | 1.42996267 |
| 43 | MP0002405_respiratory_system_inflammati | 1.41225515 |
| 44 | MP0003195_calcinosis | 1.39095867 |
| 45 | MP0003866_abnormal_defecation | 1.38400156 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.36538020 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.31209815 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.29787872 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.29449839 |
| 50 | MP0002419_abnormal_innate_immunity | 1.25773329 |
| 51 | MP0003787_abnormal_imprinting | 1.25673793 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.25621751 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.24650878 |
| 54 | MP0002429_abnormal_blood_cell | 1.21581969 |
| 55 | MP0004147_increased_porphyrin_level | 1.20362624 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.19343695 |
| 57 | MP0003045_fibrosis | 1.18713492 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.18078364 |
| 59 | MP0009115_abnormal_fat_cell | 1.16764721 |
| 60 | MP0003136_yellow_coat_color | 1.16201952 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.15169332 |
| 62 | MP0009278_abnormal_bone_marrow | 1.15093435 |
| 63 | MP0000383_abnormal_hair_follicle | 1.15021091 |
| 64 | MP0005310_abnormal_salivary_gland | 1.14231043 |
| 65 | MP0000427_abnormal_hair_cycle | 1.11814225 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.08576784 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.06941895 |
| 68 | MP0002933_joint_inflammation | 1.03216599 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.01101637 |
| 70 | MP0002653_abnormal_ependyma_morphology | 1.00009465 |
| 71 | MP0002970_abnormal_white_adipose | 0.98947380 |
| 72 | MP0002006_tumorigenesis | 0.97272557 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.95872394 |
| 74 | MP0005266_abnormal_metabolism | 0.94765144 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.93153645 |
| 76 | MP0005448_abnormal_energy_balance | 0.93120210 |
| 77 | MP0009785_altered_susceptibility_to | 0.92397610 |
| 78 | MP0010329_abnormal_lipoprotein_level | 0.91446739 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.91280351 |
| 80 | MP0005334_abnormal_fat_pad | 0.90965319 |
| 81 | MP0005171_absent_coat_pigmentation | 0.88797735 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.87034932 |
| 83 | MP0000371_diluted_coat_color | 0.86066912 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.85764681 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.84565516 |
| 86 | MP0002971_abnormal_brown_adipose | 0.84233139 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 0.81456184 |
| 88 | MP0001545_abnormal_hematopoietic_system | 0.81456184 |
| 89 | MP0004947_skin_inflammation | 0.80869455 |
| 90 | MP0001764_abnormal_homeostasis | 0.78232657 |
| 91 | MP0008469_abnormal_protein_level | 0.75735233 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.73451449 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.73169716 |
| 94 | MP0003786_premature_aging | 0.72536079 |
| 95 | MP0000609_abnormal_liver_physiology | 0.72513539 |
| 96 | MP0002822_catalepsy | 0.72404493 |
| 97 | MP0000470_abnormal_stomach_morphology | 0.69552310 |
| 98 | MP0002735_abnormal_chemical_nociception | 0.69172577 |
| 99 | MP0004742_abnormal_vestibular_system | 0.67698816 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.67547637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 3.76686181 |
| 2 | Abnormality of the fingertips (HP:0001211) | 3.72741934 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 3.72374292 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.51377373 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.26408774 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 3.22613767 |
| 7 | Stomach cancer (HP:0012126) | 3.13948578 |
| 8 | Cerebellar dysplasia (HP:0007033) | 3.06314334 |
| 9 | Abnormality of the renal cortex (HP:0011035) | 3.01100525 |
| 10 | Abnormality of T cell number (HP:0011839) | 2.99353950 |
| 11 | T lymphocytopenia (HP:0005403) | 2.96514277 |
| 12 | Clumsiness (HP:0002312) | 2.94671734 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91233500 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91233500 |
| 15 | Protruding tongue (HP:0010808) | 2.88420566 |
| 16 | Abnormality of T cells (HP:0002843) | 2.86597987 |
| 17 | Colitis (HP:0002583) | 2.80770001 |
| 18 | Attenuation of retinal blood vessels (HP:0007843) | 2.71881076 |
| 19 | Congenital stationary night blindness (HP:0007642) | 2.69079318 |
| 20 | Abnormality of B cell number (HP:0010975) | 2.68244848 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 2.66814230 |
| 22 | Agammaglobulinemia (HP:0004432) | 2.63714698 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 2.63631781 |
| 24 | Fair hair (HP:0002286) | 2.57377865 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55713852 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 2.55640308 |
| 27 | Pustule (HP:0200039) | 2.53676347 |
| 28 | Large for gestational age (HP:0001520) | 2.50181562 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43438374 |
| 30 | Hyperventilation (HP:0002883) | 2.42215253 |
| 31 | Nephronophthisis (HP:0000090) | 2.41856820 |
| 32 | Type II lissencephaly (HP:0007260) | 2.40776860 |
| 33 | Renal cortical cysts (HP:0000803) | 2.39702510 |
| 34 | Thyroiditis (HP:0100646) | 2.39090538 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.33904167 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.33326286 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.31837941 |
| 38 | Abnormality of eosinophils (HP:0001879) | 2.30484281 |
| 39 | Pancreatic cysts (HP:0001737) | 2.29329927 |
| 40 | Generalized hypopigmentation of hair (HP:0011358) | 2.29247081 |
| 41 | Granulocytopenia (HP:0001913) | 2.24380006 |
| 42 | Abnormality of DNA repair (HP:0003254) | 2.23548500 |
| 43 | Hypochromic anemia (HP:0001931) | 2.23134458 |
| 44 | Hypoplasia of the thymus (HP:0000778) | 2.21427800 |
| 45 | Recurrent viral infections (HP:0004429) | 2.21164697 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.20922869 |
| 47 | Recurrent bronchitis (HP:0002837) | 2.18672803 |
| 48 | Amelogenesis imperfecta (HP:0000705) | 2.15047454 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.12896507 |
| 50 | IgG deficiency (HP:0004315) | 2.11210145 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09925839 |
| 52 | Meningitis (HP:0001287) | 2.08022508 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.07256535 |
| 54 | Prominent nose (HP:0000448) | 2.07161939 |
| 55 | Dysmetric saccades (HP:0000641) | 2.05726900 |
| 56 | Patellar aplasia (HP:0006443) | 2.05240596 |
| 57 | Partial agenesis of the corpus callosum (HP:0001338) | 2.04828309 |
| 58 | Stomatitis (HP:0010280) | 2.04164817 |
| 59 | Encephalitis (HP:0002383) | 2.03746106 |
| 60 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.99558571 |
| 61 | Chronic hepatic failure (HP:0100626) | 1.96577644 |
| 62 | Eosinophilia (HP:0001880) | 1.96357816 |
| 63 | Hypoplasia of the pons (HP:0012110) | 1.96158701 |
| 64 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95771418 |
| 65 | Abnormality of the sella turcica (HP:0002679) | 1.95342799 |
| 66 | Abnormality of the pons (HP:0007361) | 1.91828572 |
| 67 | Lissencephaly (HP:0001339) | 1.91421531 |
| 68 | Myositis (HP:0100614) | 1.89664172 |
| 69 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.88840250 |
| 70 | Tubular atrophy (HP:0000092) | 1.87911521 |
| 71 | J-shaped sella turcica (HP:0002680) | 1.87430199 |
| 72 | Duplicated collecting system (HP:0000081) | 1.86964694 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 1.86594640 |
| 74 | Combined immunodeficiency (HP:0005387) | 1.86096396 |
| 75 | Tachypnea (HP:0002789) | 1.85295730 |
| 76 | Acute lymphatic leukemia (HP:0006721) | 1.84871213 |
| 77 | Abnormal drinking behavior (HP:0030082) | 1.83869418 |
| 78 | Polydipsia (HP:0001959) | 1.83869418 |
| 79 | Chronic diarrhea (HP:0002028) | 1.83121550 |
| 80 | Progressive inability to walk (HP:0002505) | 1.82815775 |
| 81 | Chest pain (HP:0100749) | 1.82441963 |
| 82 | Ketoacidosis (HP:0001993) | 1.81784354 |
| 83 | Retrobulbar optic neuritis (HP:0100654) | 1.81368112 |
| 84 | Optic neuritis (HP:0100653) | 1.81368112 |
| 85 | Eczematoid dermatitis (HP:0000976) | 1.81131422 |
| 86 | Progressive microcephaly (HP:0000253) | 1.81055065 |
| 87 | Abnormality of alanine metabolism (HP:0010916) | 1.79207900 |
| 88 | Hyperalaninemia (HP:0003348) | 1.79207900 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79207900 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 1.78595536 |
| 91 | Ketosis (HP:0001946) | 1.78317023 |
| 92 | Basal cell carcinoma (HP:0002671) | 1.77906053 |
| 93 | Abnormality of the prostate (HP:0008775) | 1.77565286 |
| 94 | Abnormality of the nasal septum (HP:0000419) | 1.75536133 |
| 95 | Prolonged bleeding time (HP:0003010) | 1.73636109 |
| 96 | Leukocytosis (HP:0001974) | 1.72417618 |
| 97 | Prostate neoplasm (HP:0100787) | 1.72057021 |
| 98 | Neonatal hypoglycemia (HP:0001998) | 1.71189755 |
| 99 | Acute hepatic failure (HP:0006554) | 1.70924597 |
| 100 | B lymphocytopenia (HP:0010976) | 1.70290084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.54186042 |
| 2 | TAOK3 | 3.50668466 |
| 3 | MAP4K1 | 2.88701137 |
| 4 | CDK12 | 2.59034228 |
| 5 | TXK | 2.10939459 |
| 6 | TNK2 | 1.97417978 |
| 7 | IRAK4 | 1.90047696 |
| 8 | BMPR1B | 1.89259356 |
| 9 | BRD4 | 1.89008175 |
| 10 | TLK1 | 1.84624977 |
| 11 | GRK6 | 1.82997541 |
| 12 | MAP3K7 | 1.81923422 |
| 13 | TRIB3 | 1.79298704 |
| 14 | ZAK | 1.76358049 |
| 15 | SIK2 | 1.72372562 |
| 16 | WNK4 | 1.64252924 |
| 17 | AKT3 | 1.55663529 |
| 18 | BLK | 1.54872503 |
| 19 | EEF2K | 1.52544072 |
| 20 | BTK | 1.51366240 |
| 21 | MAP2K2 | 1.49080511 |
| 22 | MAP3K14 | 1.40941628 |
| 23 | ICK | 1.38449994 |
| 24 | IKBKE | 1.37272675 |
| 25 | ITK | 1.36373010 |
| 26 | MAPK11 | 1.29227375 |
| 27 | SYK | 1.27483356 |
| 28 | FES | 1.27421877 |
| 29 | INSRR | 1.21050050 |
| 30 | IKBKB | 1.20885776 |
| 31 | KIT | 1.20277128 |
| 32 | TRPM7 | 1.19700177 |
| 33 | MARK3 | 1.18485392 |
| 34 | CAMK1D | 1.12100678 |
| 35 | CAMKK1 | 1.09002845 |
| 36 | MAP4K2 | 1.07646727 |
| 37 | MAPKAPK3 | 1.06301138 |
| 38 | ERN1 | 1.05974685 |
| 39 | ZAP70 | 1.03357421 |
| 40 | MARK2 | 1.03303152 |
| 41 | MAP2K3 | 1.03231153 |
| 42 | JAK1 | 1.01321676 |
| 43 | TYK2 | 1.01004015 |
| 44 | LCK | 0.98982256 |
| 45 | EPHA3 | 0.97931049 |
| 46 | CHUK | 0.96828779 |
| 47 | CSF1R | 0.96708600 |
| 48 | FGFR4 | 0.95744948 |
| 49 | OXSR1 | 0.94086535 |
| 50 | RIPK4 | 0.93918523 |
| 51 | JAK3 | 0.93339936 |
| 52 | PRKAA2 | 0.90843534 |
| 53 | ADRBK2 | 0.89552237 |
| 54 | DAPK2 | 0.88417332 |
| 55 | MAPK13 | 0.86914388 |
| 56 | NEK6 | 0.86857041 |
| 57 | TEC | 0.82478231 |
| 58 | RPS6KA6 | 0.81975016 |
| 59 | CAMKK2 | 0.80331420 |
| 60 | NLK | 0.79826070 |
| 61 | WNK1 | 0.79101676 |
| 62 | PRKAA1 | 0.77398514 |
| 63 | STK11 | 0.77280344 |
| 64 | LYN | 0.76681477 |
| 65 | MAP2K6 | 0.76277711 |
| 66 | HCK | 0.76242294 |
| 67 | MAPK12 | 0.76052304 |
| 68 | PIK3CG | 0.75856660 |
| 69 | STK39 | 0.75203684 |
| 70 | ACVR1B | 0.73044752 |
| 71 | PIK3CA | 0.71902305 |
| 72 | SIK1 | 0.71207280 |
| 73 | TBK1 | 0.70611030 |
| 74 | CDK4 | 0.70144410 |
| 75 | HIPK2 | 0.66664323 |
| 76 | MAP3K13 | 0.65532878 |
| 77 | PIM1 | 0.65043069 |
| 78 | JAK2 | 0.65015281 |
| 79 | MTOR | 0.63899284 |
| 80 | MAPK15 | 0.63811330 |
| 81 | PKN2 | 0.58473398 |
| 82 | IRAK1 | 0.58101786 |
| 83 | PDK1 | 0.57812506 |
| 84 | CAMK1G | 0.56612955 |
| 85 | RPS6KA5 | 0.55728255 |
| 86 | FGFR3 | 0.55662575 |
| 87 | CAMK4 | 0.53830139 |
| 88 | CDC42BPA | 0.52697390 |
| 89 | RPS6KB2 | 0.51145788 |
| 90 | RPS6KL1 | 0.51106585 |
| 91 | RPS6KC1 | 0.51106585 |
| 92 | SGK2 | 0.50320862 |
| 93 | PRKCQ | 0.50295012 |
| 94 | MAPK3 | 0.49345588 |
| 95 | ATR | 0.48067335 |
| 96 | MAPK7 | 0.47511673 |
| 97 | MAP3K10 | 0.47312203 |
| 98 | TESK2 | 0.44199977 |
| 99 | STK38 | 0.44034300 |
| 100 | PRKCH | 0.43126960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.12779599 |
| 2 | ABC transporters_Homo sapiens_hsa02010 | 2.75719858 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01415592 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94937912 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87962395 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86014590 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83671130 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76208152 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.71819437 |
| 10 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.71671753 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56108840 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55063516 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51781038 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39353283 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37484129 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36898498 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35184664 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26895891 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.25218271 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.24618605 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23904285 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21943180 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.20675294 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20415666 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.17393310 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16340770 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15926022 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13353164 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10094474 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.09221173 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08772392 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.08720368 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08654744 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03109315 |
| 35 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02411431 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01848044 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.01817818 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00742396 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00681231 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00075034 |
| 41 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.99579442 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99061885 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97677060 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97298125 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94990838 |
| 46 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92377142 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92321769 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89413509 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89187039 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89147599 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85654145 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85572921 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85387845 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84766376 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84402175 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83588012 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82518216 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.82495374 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82192417 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82008136 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80639764 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80237175 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79808141 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79778169 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77251739 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75731836 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.72918145 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69403319 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.68844516 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67549487 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.66634928 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65385190 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65044468 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63921657 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63368573 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62255490 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.61937402 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61668603 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61340398 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60975373 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.58729526 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58442505 |
| 83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58331045 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57970146 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56906214 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.56767098 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55762554 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52638319 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52620427 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51167304 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50662810 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50534244 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50096849 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49032169 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.48740249 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48318959 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48034570 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47894288 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47350724 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46822996 |

